Recent Headlines
Within Chemical Manufacturing
FuseBio Presents New Data at AACR: Targeting a Functionally-Selective IL-18 (F-18) to PD-1: A Next Generation Checkpoint Inhibitor with Enhanced Anti-Tumor Activity
FuseBio's unique attenuation mechanism renders IL-18, a functionally selective IL-18, resistant to IL-18BP and 1 million percent less active in circulation and yet still retain nearly full activity when targeted to PD-1+/IL-18R+ cells, the key functional immune cells in tumors. It is designed to retain full activity of PD-1 checkpoint blockade and simultaneously deliver a functionally selective IL-18 (F-18) to preserve and enhance the anti-tumor activity of immune cells. - April 09, 2024 - Fuse Biotherapeutics
Ombra Group Acquires 75% of IUT Medical GmbH to Propel Next-Generation Gas and Chemical Detection
Ombra Group Inc, a global pioneer in advanced technology solutions, today announced its acquisition of IUT Medical GmbH, a world-renowned German company specializing in cutting-edge gas and hazardous chemical detection systems. Founded in 1998 by the late Prof. Dr. Jürgen Leonhardt, IUT... - April 09, 2024 - The Ombra Group Inc.
Perma-Fix Successfully Completes Pilot Plant Testing and Unveils New Process for Destruction of PFAS “Forever Chemicals”
Perma-Fix Environmental Services, Inc. (the “Company”) today announced it has successfully completed pilot plant testing on its new, patent-pending process for the destruction of Per- and Polyfluorinated Substances (PFAS), commonly known as “forever chemicals.” - April 08, 2024 - Perma-Fix
Renowned Advocate Lorrinda Gray-Davis to Speak at TRIO's Remember & Rejoice Event
As a guest speaker, Lorrinda Gray-Davis will share her personal journey of hope, resilience, and gratitude, highlighting the profound impact of organ donation on individuals, families, and communities. "Remember & Rejoice" stands as the single largest gathering of donor families and transplant recipients in the country, providing a sacred space for reflection, remembrance, and rejoicing. - April 06, 2024 - TRIO-Oklahoma
AMPP 2024: Triumph, Innovation, and Solidarity Define the Annual Conference + Expo in New Orleans
The 2024 AMPP Conference in New Orleans highlighted achievements, resilience, and global industry unity against challenges. - April 06, 2024 - AMPP
Groundbreaking Research Validates Biome Makers’ BeCrop Soil Intelligence Technology
Biome Makers, a global agtech company, proudly announces its contribution to the publication of two scientific studies validating the efficacy and reliability of the company’s revolutionary technology. These landmark papers demonstrate a significant leap forward in the field of soil health intelligence and predicting soil functionality. - April 06, 2024 - Biome Makers
Ngram Expands AI Dataset Offerings with Descriptive Question Answering for Healthcare
New open-source medchat-qa-descriptive dataset enables AI models to provide comprehensive answers to complex medical queries. - March 22, 2024 - ngram Inc.
Parvus Announces Collaboration with AbbVie to Develop IBD Therapies Based on the Parvus Navacim Platform Technology
The collaboration will combine AbbVie’s expertise in Immunology with Parvus’ innovative Navacim™ regulatory T cells (Treg) immune tolerization platform technology to develop therapies for Inflammatory Bowel Disease Parvus Therapeutics announced today that it has entered into an... - March 20, 2024 - Parvus Therapeutics U.S., Inc.
AMD Stopper, a New Treatment for Age-Related Macular Degeneration, Seeks Partnerships with Manufacturers in the Healthcare Industry
California inventor of oral treatment for Age-Related Macular Degeneration, a common eye disease which affects tens of millions globally, is working tirelessly to bring his formulation to market. - March 20, 2024 - AMD Stopper
Ease.io Boosts Growth Trajectory with Strategic Appointment of Russell Mullin as Chief Revenue Officer
This pivotal hire underscores Ease.io's commitment to scaling its global footprint and further accelerating product expansion and adoption among manufacturers worldwide. - March 19, 2024 - Ease Inc.
ACL Digital and PhoenixAI.tech Partner to Take AI-Driven Drone Technology to New Heights
The strategic partnership enhances ACL Digital’s capabilities with PhoenixAI.tech, focusing on AI drone solutions for UAVs, IoT, and edge computing to revolutionize operations significantly Beyond Visual Line of Sight (BVLOS) missions. - March 16, 2024 - ACL Digital
iView Therapeutics Inc. Announced FDA’s Clearance of IND Application for IVW-1001 Ophthalmic Eyelid Wipe to Treat Signs and Symptoms of Dry Eye Disease
iView Therapeutics Inc., a clinical stage biotechnology company dedicated to advancing innovative treatments for ocular diseases, announces that the U.S. Food and Drug Administration (FDA) cleared iView’s Investigational New Drug (IND) application to for the initiation of a Phase 1/2 clinical... - March 11, 2024 - iView Therapeutics Inc.
Defined Bioscience Introduces Ready-CEPT™: A New Cell Viability Enhancer
Defined Bioscience is pleased to announce the launch of Ready-CEPT™ 1000X, a new product designed to improve stem cell survival, growth, and health during critical processes such as routine passaging, cryopreservation, and freeze-thaw recovery. - March 11, 2024 - Defined Bioscience Inc.
Utech Products Inc. Achieves ISO 9001
Utech Products Inc. Achieves ISO 9001 Certification (Certification Registration No. 961 24 5889), Demonstrating Commitment to Quality and Customer Satisfaction. - March 09, 2024 - Utech Products Inc.
New Guide from EU Automation: Reducing Costs and Boosting Uptime with Condition-Based Maintenance and Real-Time Monitoring
Automation parts supplier EU Automation has published a new guide for engineers wanting to deploy condition-based maintenance (CBM) to improve operating efficiencies and increase profitability. It provides valuable insight so engineers can best implement a CBM strategy to realise its full benefits. - March 01, 2024 - EU Automation
IVIEW Announces Presentation of Positive Topline Results in Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis at ARVO 2024
IVIEW Therapeutics Inc. announces to present the positive topline result in the Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis in the upcoming 2024 ARVO (The Association for Research in Vision and Ophthalmology) national meeting in Seattle, WA. The Presentation... - February 28, 2024 - iView Therapeutics Inc.
Cayman Chemical Introduces LipidLaunch™, Expands Portfolio of Lipid Nanoparticle Research Tools to Support Advances in RNA Therapies
Cayman Chemical introduces the latest addition to the company’s portfolio of lipid nanoparticle (LNP) research tools for academic, pharma, and biotech researchers worldwide. The LipidLaunch™ product line helps researchers pursue LNPs for the delivery of nucleic acid therapies in untold health applications, ranging from vaccine development to cancer and cell or gene therapies. - February 22, 2024 - Cayman Chemical Company
AMPP Announces Winners of the 3rd Annual Diversity and Inclusion Grants
AMPP has announced the winners of its 3rd Annual Diversity and Inclusion Grants. - February 16, 2024 - AMPP
Gotham Biotech’s Histoplasma Urinary Antigen EIA Kit Now Available for Purchase as Histoplasma Spreads in the U.S.
Histoplasmosis is a systemic disease caused by the thermally dimorphic fungus Histoplasma capsulatum. H. capsulatum is distributed worldwide and endemic to the Ohio and Mississippi River Valleys, where the CDC estimates 60% to 90% of people who live in the region have been exposed to the fungus at some point during their life, and to certain regions of Central and South America. Medicare records from 2007 to 2016 have found cases of histoplasmosis have now spread to 47 states and Washington, DC. - February 15, 2024 - Gotham Biotech
AMPP Champions Leadership and Inclusion at 2024 Annual Conference + Expo with Valuing Voices Forum
AMPP aims to provide its members with valuable events designed to empower leaders and promote diversity, equity, and inclusion (DEI) in the workplace at the AMPP Annual Conference and Expo. - February 15, 2024 - AMPP
AMPP Welcomes New Board Member to Strengthen Its Commitment to the Transportation Sector
AMPP welcomes Todd Bennett to its Board of Directors, effective immediately. This addition is a key step in deepening AMPP's commitment to the transportation sector. - February 15, 2024 - AMPP
GENINVO, a Leading Provider of Life Science Product and Business Solutions Announced the Offering of Its On-Demand Service/Tool: ApoGI™
ApoGI™ is an integrated, one stop automation platform that leverages Artificial Intelligence and Machine Learning algorithms to focus on standards and metadata driven generation of artifacts. The Primary objective of this platform is to help SMEs (Subject matter experts) focus on curating... - February 15, 2024 - GenInvo, Inc.
NAD3® Supplement Study: Memphis Health Sciences College Discovers Key to Cellular Rejuvenation
In a groundbreaking development, the College of Health Sciences at the University of Memphis, spearheaded by leading researchers Janine Hellenbrand, Richard J. Bloomer, and Marie Van der Merwe, has revealed the remarkable effects of NAD3® supplementation on adult stem cell circulation in... - February 14, 2024 - High Performance Nutrition
Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report
Sponsor Outsourcing Dollars May Shift to Clinical Site Networks, Transforming the CRO Relationship - February 13, 2024 - Life Science Strategy Group, LLC
Microvascular Therapeutics Welcomes Thom Tulip as Chief Business Officer
Microvascular Therapeutics Inc. (MVT), a clinical-stage biotech company at the forefront of developing the next generation of microbubbles unlocking the therapeutic potential of ultrasound, proudly announces the appointment of Dr Thom Tulip as their new Chief Business Officer. In this pivotal role, Dr Tulip will lead capital raises to propel MVT's cutting-edge technologies into the market. - February 10, 2024 - Microvascular Therapeutics, Inc.
Flow Circuits and Rapid Fluidics Ltd. Announce Partnership to Drive Microfluidic Innovation
Flow Circuits design platform and Rapid Fluidics 3D Print capabilities perfectly complement each other for rapid fluidic system development. Combined they empower researchers in diverse markets such as Pharmaceutical & Life Sciences Research, Point of Care Testing and Clinical Diagnostics, and Environment and Industrial Analytics. - February 05, 2024 - Rapid Fluidics Ltd
Accelerating Drug Discovery: Life Science and IT Leaders Explore the Power of Artificial Intelligence April 15-17 in Boston
AI to Take Center Stage at Bio-IT World Conference & Expo, the Hub for Pharmaceutical, Biotech and IT Collaboration - February 04, 2024 - Cambridge Healthtech Institute
RIOT Wireless Tank Level Monitoring Solution Honored for Excellence in Innovation
The RIOT Edge Solutions’ Wireless tank-level monitoring solution utilizes a fully integrated, rugged tank level monitoring device, mobile app and remote visibility via API, allowing enterprise users to integrate sensor data in their own or preferred visualization and automation tools as well as processes. - February 04, 2024 - RIOT Edge Solutions
SocoFlame, Inc. (a Subsidiary of Groupe Socomore) Completes Acquisition of the Flamemaster Corporation
SocoFlame, Inc. (a subsidiary of Groupe Socomore) announced that it has closed its acquisition of the Flamemaster Corporation following the completion of its previously announced tender offer for all outstanding shares of common stock of the Flamemaster Corporation. SocoFlame, Inc. (a subsidiary of... - February 02, 2024 - Flamemaster Corporation
Patient Experience and Satisfaction with Electronic Consent, Onboarding, and Diaries in Clinical Trials Report
New Market Research Shows Different Patient Preferences for Electronic Diaries - January 31, 2024 - Life Science Strategy Group, LLC
Ease.io Marks a Stellar 2023 with Industry-Leading Achievements and Robust Growth
Ease.io experienced substantial user expansion, high customer satisfaction, and industry recognition, underscoring its commitment to advancing manufacturing quality and safety. - January 29, 2024 - Ease Inc.
Second Anniversary of Fern Hollow Bridge Collapse Highlights Urgent Need for Corrosion Control in National Infrastructure
On January 28, 2024, the second anniversary of the Fern Hollow bridge collapse near Frick Park in Pittsburgh will be observed, a tragedy that highlighted significant vulnerabilities in America's infrastructure, particularly emphasizing the critical issue of corrosion. - January 28, 2024 - AMPP
New Sustainable Lyophilization Technology Uses Supercritical CO2
The Thar group of companies have been using CO2 for extraction, purification, particle design and encapsulation for many years but recent developments point to a need for sustainable methods for drying APIs, intermediates, excipients and biologics at relatively low temperatures. 'Big Pharma' has depended on Thar for SFC tools in drug discovery but lyophilization will likely be used in manufacturing too. - January 28, 2024 - Thar Process, LLC
AMPP Announces Winners of 2024 Annual Service and Technical Awards
The Association for Materials Protection and Performance (AMPP) revealed the 2024 awardees for its service and technical distinctions. These awards will be presented at the AMPP Annual Conference + Expo, scheduled for March 3-7, 2024, in New Orleans, Louisiana. - January 27, 2024 - AMPP
Family-Owned Boone Labs and Melk Cannabis Unite to Elevate Michigan's Cannabis Culture
Boone Labs, a distinguished family-owned and operated cannabis processing facility in Michigan, is excited to announce a strategic partnership with Melk Cannabis, a premium solventless brand celebrated for its commitment to excellence and vibrant contributions to the cannabis community. This... - January 24, 2024 - Boone Labs
Huntington Study Group Announces 2024 Annual Meeting
The Huntington Study Group® (HSG), together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease (HD), is pleased to announce that its annual meeting for 2024 is slated to take place from November 6-9 at the... - January 22, 2024 - Huntington Study Group
Johari Digital Healthcare Limited Hosts Successful Webinar on Design for Manufacturing (DFM) for Medical Devices
Johari Digital Healthcare hosted a successful webinar on "Building Cost-effective Medical Devices through Design for Manufacturing." The 60-minute event discussed challenges in balancing cost and product robustness, featuring real-world case studies. Speakers highlighted early DFM benefits, such as cost reduction and faster time-to-market. - January 22, 2024 - Johari Digital Healthcare Ltd.
Alpyne Strategy’s Elizabeth Ortlieb to Host Refrigerant Briefing at 2024 AHR Expo
Learn the latest refrigerant updates in 2024 at the world’s largest HVACR expo. - January 19, 2024 - Alpyne Strategy
Impact of the In Vitro Diagnostic Regulation on Clinical Trials in the EU and CRO Outsourcing Report
IVDR Delays Driving Trial Sponsors to Actively Seek Alternative Site and CRO Outsourcing Strategies - January 17, 2024 - Life Science Strategy Group, LLC
EU Automation Publishes New Guide: How to Get Robotics Right - Avoiding the Common Costly Mistakes of Automation Adoption
Automation parts supplier EU Automation has published a new guide about industrial robotics implementation and how to avoid the common costly mistakes of automation adoption. - January 17, 2024 - EU Automation
Pillar Technologies Surface Treaters Announces New Sales Relationship with C.C. Steven & Associates
The Pillar Technologies Surface Treatment team is thrilled to announce the addition of its new Sales Representative, C.C. Steven & Associates. Located in Camarillo, California, C.C. Steven & Associates has been solving static mitigation challenges, offering manufacturing solutions and... - January 15, 2024 - ITW Air Management
New Ultra-Thin, Compact Low-Height, Low-Frequency Vibration Isolation Platform Adapts to Space Constraints in Critical Micro- and Nano-Microscopy
At about 2-1/2 inches in height, while isolating vibrations as low as 1 hertz, the new completely-passive Negative-Stiffness tabletop vibration isolation platform – developed by Minus K Technology – provides the industry’s thinnest low-height, low-frequency isolator for Microscopy (SPM, SEM, AFM, etc.), Micro-Hardness and Nano-Indenter Testing, Laser/Optical Systems, Biology/Neuroscience Systems, Spacecraft Ground Testing, Analytical Balances, Audio Reproduction, Vacuum & Cleanroom applications. - January 10, 2024 - Minus K Technology Inc.
Sterilex Announces Leadership Transition
Sterilex LLC, a Paine Schwartz Partners portfolio company and a leading developer of innovative food safety antimicrobial products, is embarking on a new chapter with a leadership transition. - January 05, 2024 - Sterilex
ALPCO Announces the Commercial Launch of Its FDA 510(K) Cleared Calprotectin Immunoturbidimetric Assay
American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, proudly announces the commercial launch of its FDA 510(k) cleared Calprotectin Immunoturbidimetric Assay, enhancing its suite of Gastrointestinal (GI) diagnostic solutions. In July... - December 19, 2023 - ALPCO
Johari Digital Healthcare Ltd. Clinches Prestigious "Pharmaceutical & Healthcare MSME of the Year" Award at ET MSME Awards 2023
Johari Digital Healthcare Ltd. has clinched the esteemed "Pharmaceutical & Healthcare MSME of the Year" award at the ET MSME Awards 2023 in New Delhi. Celebrating the resilience of India's MSME sector, the event recognized Johari Digital Healthcare Ltd. for its exceptional contributions to healthcare, particularly in manufacturing and research & development. - December 18, 2023 - Johari Digital Healthcare Ltd.
Empowering Data Privacy: GENINVO Offers Anonymization as a Service
GENINVO, a leading provider of life science product and business solutions announced the offering of its on-demand service Anonymization as a Service. GENINVO a trailblazer in data privacy solutions, is excited to introduce its ground-breaking offering, Anonymization as a Service. With data... - December 14, 2023 - GenInvo, Inc.
Huntington Study Group and Roche Collaborate on GENERATION HD2 Study
The Huntington Study Group together with its wholly-owned clinical research organization, HSG Clinical Research, Inc. (HSGCR), is pleased to announce a collaboration with Roche-Genentech to optimize our collective experiences in Huntington’s disease (HD) clinical research. Together we are... - December 13, 2023 - Huntington Study Group
Breakthrough Study by Microvascular Therapeutics Reveals Fibrin-Targeted Phase Shift Microbubbles as Promising Solution for Microvascular Obstruction
Microvascular Therapeutics, a trailblazing healthcare research and development company, announces a groundbreaking study on the treatment of Microvascular Obstruction (MVO) through sonoreperfusion. The study, led by Dr. John J. Pacella and his team at the Center for Ultrasound Molecular Imaging and... - December 13, 2023 - Microvascular Therapeutics, Inc.
Microvascular Therapeutics Selected as a Participant in the 2023 H7 BioCapital Accelerator Program
Microvascular Therapeutics (MVT), a clinical stage biopharma pioneering the potential of ultrasound in diagnostics and theranostics, has been selected to join the prestigious H7 Healthcare Accelerator 2023 Cohort, powered by H7 BioCapital. The program is renowned for providing a dynamic platform... - December 13, 2023 - Microvascular Therapeutics, Inc.
AMPP Announces Dr. Michio Kaku as Annual Conference Keynote Speaker
The Association for Materials Protection and Performance unveils that well-known physicist Dr. Michio Kaku will be the keynote speaker for its upcoming AMPP Annual Conference + Expo. - December 10, 2023 - AMPP